Your browser doesn't support javascript.
loading
Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxel.
Narita, Shintaro; Kimura, Takahiro; Hatakeyama, Shingo; Hata, Kenichi; Yanagisawa, Takafumi; Maita, Shinya; Chiba, Shuji; Sato, Hiromi; Kashima, Soki; Koizumi, Atsushi; Yamamoto, Ryohei; Takayama, Koichiro; Okane, Katsumi; Ishida, Toshiya; Horikawa, Yohei; Kumazawa, Teruaki; Shimoda, Jiro; Suzuki, Takehiro; Ohyama, Chikara; Egawa, Shin; Habuchi, Tomonori.
Afiliação
  • Narita S; Department of Urology, Akita University School of Medicine, Akita, Japan. naritashintaro@gmail.com.
  • Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Hatakeyama S; Department of Urology, Hirosaki University School of Medicine, Hirosaki, Japan.
  • Hata K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Yanagisawa T; Department of Urology, Atsugi City Hospital, Kanagawa, Japan.
  • Maita S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Chiba S; Department of Urology, Iwate Prefectural Isawa Hospital, Mizusawa, Japan.
  • Sato H; Department of Urology, Yuri Kumiai General Hospital, Honjo, Japan.
  • Kashima S; Department of Urology, Akita University School of Medicine, Akita, Japan.
  • Koizumi A; Department of Urology, Akita University School of Medicine, Akita, Japan.
  • Yamamoto R; Department of Urology, Akita University School of Medicine, Akita, Japan.
  • Takayama K; Department of Urology, Akita University School of Medicine, Akita, Japan.
  • Okane K; Department of Urology, Yokote City Hospital, Yokote, Japan.
  • Ishida T; Department of Urology, Akita Kosei Medical Center, Akita, Japan.
  • Horikawa Y; Department of Urology, Akita City Hospital, Akita, Japan.
  • Kumazawa T; Department of Urology, Akita Red Cross Hospital, Akita, Japan.
  • Shimoda J; Department of Urology, Omagari Kosei Medical Center, Daisen, Japan.
  • Suzuki T; Department of Urology, Iwate Prefectural Isawa Hospital, Mizusawa, Japan.
  • Ohyama C; Department of Urology, Hiraka General Hospital, Yokote, Japan.
  • Egawa S; Department of Urology, Hirosaki University School of Medicine, Hirosaki, Japan.
  • Habuchi T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Int J Clin Oncol ; 27(9): 1477-1486, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35748967
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article